This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Osaka University. Active years: 2021.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2021
Title: Keisuke Shirakura: Innovator in Blood-Brain Barrier Research
Introduction
Keisuke Shirakura is a prominent inventor based in Osaka, Japan. He has made significant contributions to the field of medical science, particularly in the area of controlling the blood-brain barrier. His innovative work has the potential to impact various therapeutic approaches.
Latest Patents
Shirakura holds a patent for a Claudin 5 antibody and a medicine containing said antibody. This novel technique provides a method for controlling the blood-brain barrier. The antibody targets a specific epitope within an extracellular domain of the Claudin 5 protein, which is crucial for maintaining the integrity of the blood-brain barrier.
Career Highlights
Keisuke Shirakura is affiliated with Osaka University, where he conducts his research. His work has garnered attention for its potential applications in treating neurological disorders. With a focus on innovative solutions, he continues to advance the understanding of the blood-brain barrier.
Collaborations
Shirakura collaborates with notable colleagues, including Yoshiaki Okada and Masuo Kondoh. Their combined expertise enhances the research efforts and contributes to the development of effective medical interventions.
Conclusion
Keisuke Shirakura's contributions to the field of medical science, particularly through his patent on the Claudin 5 antibody, highlight his role as an innovator. His work at Osaka University and collaborations with esteemed colleagues further emphasize the importance of his research in advancing therapeutic strategies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile